RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 550,000 shares; 2025Q1: 250,000 shares; 2025Q2: 325,000 shares; 2025Q3: 400,000 shares; 2025Q4: 1,200,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 1,500,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $130M 7.97% -500,000 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,550,000 shares; 2025Q1: 1,550,000 shares; 2025Q2: 1,600,000 shares; 2025Q3: 1,600,000 shares; 2025Q4: 1,250,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 1,600,000 shares; 2026Q3: 1,600,000 shares 1,600,000 $129M 7.89% 0 Timeline EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 550,000 shares; 2025Q1: 675,000 shares; 2025Q2: 1,000,000 shares; 2025Q3: 1,500,000 shares; 2025Q4: 1,500,000 shares; 2026Q1: 1,600,000 shares; 2026Q2: 2,000,000 shares; 2026Q3: 2,400,000 shares 2,400,000 $97.4M 5.96% +400,000 Timeline CYTK CYTOKINETICS INC More: the full row for CYTOKINETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,000,000 shares; 2025Q1: 1,100,000 shares; 2025Q2: 1,000,000 shares; 2025Q3: 1,400,000 shares; 2025Q4: 1,400,000 shares; 2026Q1: 1,600,000 shares; 2026Q2: 1,600,000 shares; 2026Q3: 1,600,000 shares 1,600,000 $72.5M 4.43% 0 Timeline MRK MERCK & CO INC More: the full row for MERCK & CO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 200,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 250,000 shares; 2026Q1: 425,000 shares; 2026Q2: 350,000 shares; 2026Q3: 450,000 shares 450,000 $65.4M 4% +100,000 Timeline SRRK SCHOLAR ROCK HLDG CORP More: the full row for SCHOLAR ROCK HLDG CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 375,000 shares; 2025Q1: 125,000 shares; 2025Q2: 100,000 shares; 2025Q3: 100,000 shares; 2025Q4: 300,000 shares; 2026Q1: 500,000 shares; 2026Q2: 750,000 shares; 2026Q3: 1,255,000 shares 1,255,000 $60.6M 3.71% +505,000 Timeline CNC CENTENE CORP DEL More: the full row for CENTENE CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 400,000 shares; 2025Q4: 650,000 shares; 2026Q1: 650,000 shares; 2026Q2: 300,000 shares; 2026Q3: 750,000 shares 750,000 $46.6M 2.85% +450,000 Timeline AXSM AXSOME THERAPEUTICS INC. More: the full row for AXSOME THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 35,000 shares; 2026Q2: 300,000 shares; 2026Q3: 250,000 shares 250,000 $46.1M 2.82% -50,000 Timeline VERA VERA THERAPEUTICS INC More: the full row for VERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,150,000 shares; 2025Q1: 1,150,000 shares; 2025Q2: 1,150,000 shares; 2025Q3: 1,700,000 shares; 2025Q4: 1,800,000 shares; 2026Q1: 1,600,000 shares; 2026Q2: 1,750,000 shares; 2026Q3: 1,500,000 shares 1,500,000 $32.3M 1.97% -250,000 Timeline AMGN AMGEN INC More: the full row for AMGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 75,000 shares 75,000 $31.6M 1.93% new Timeline LFST LIFESTANCE HEALTH GROUP INC More: the full row for LIFESTANCE HEALTH GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,500,000 shares; 2025Q4: 3,000,000 shares; 2026Q1: 4,300,000 shares; 2026Q2: 3,000,000 shares; 2026Q3: 2,600,000 shares 2,600,000 $31.3M 1.91% -400,000 Timeline REGN REGENERON PHARMACEUTICALS More: the full row for REGENERON PHARMACEUTICALS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,000 shares; 2025Q3: 50,000 shares; 2025Q4: 105,000 shares; 2026Q1: 85,000 shares; 2026Q2: 40,000 shares; 2026Q3: 40,000 shares 40,000 $30.3M 1.85% 0 Timeline THC TENET HEALTHCARE CORP More: the full row for TENET HEALTHCARE CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 400,000 shares; 2025Q1: 275,000 shares; 2025Q2: 275,000 shares; 2025Q3: 300,000 shares; 2025Q4: 100,000 shares; 2026Q1: not reported; 2026Q2: 165,000 shares; 2026Q3: 90,000 shares 90,000 $23M 1.41% -75,000 Timeline BIIB BIOGEN INC More: the full row for BIOGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares; 2026Q1: 60,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000 $22.6M 1.38% 0 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 200,000 shares; 2026Q1: 450,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $22.5M 1.37% 0 Timeline CAH CARDINAL HEALTH INC More: the full row for CARDINAL HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 250,000 shares; 2025Q1: not reported; 2025Q2: 140,000 shares; 2025Q3: 130,000 shares; 2025Q4: 200,000 shares; 2026Q1: 270,000 shares; 2026Q2: 300,000 shares; 2026Q3: 100,000 shares 100,000 $22.2M 1.36% -200,000 Timeline CVS CVS HEALTH CORP More: the full row for CVS HEALTH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,000 shares; 2025Q1: 200,000 shares; 2025Q2: 250,000 shares; 2025Q3: 200,000 shares; 2025Q4: 500,000 shares; 2026Q1: 150,000 shares; 2026Q2: 1,100,000 shares; 2026Q3: 500,000 shares 500,000 $21.4M 1.31% -600,000 Timeline NBIX NEUROCRINE BIOSCIENCES INC More: the full row for NEUROCRINE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 160,000 shares; 2025Q1: 150,000 shares; 2025Q2: 150,000 shares; 2025Q3: 150,000 shares; 2025Q4: 150,000 shares; 2026Q1: 150,000 shares; 2026Q2: 150,000 shares; 2026Q3: 150,000 shares 150,000 $21.3M 1.3% 0 Timeline VRTX VERTEX PHARMACEUTICALS INC More: the full row for VERTEX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,000 shares; 2026Q2: 40,000 shares; 2026Q3: 40,000 shares 40,000 $20.9M 1.28% 0 Timeline ORIC ORIC PHARMACEUTICALS INC More: the full row for ORIC PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,250,000 shares; 2025Q3: 900,000 shares; 2025Q4: 1,200,000 shares; 2026Q1: 1,400,000 shares; 2026Q2: 1,900,000 shares; 2026Q3: 1,700,000 shares 1,700,000 $20.2M 1.24% -200,000 Timeline BBIO BRIDGEBIO PHARMA INC More: the full row for BRIDGEBIO PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 100,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 275,000 shares; 2026Q2: 275,000 shares; 2026Q3: 300,000 shares 300,000 $19.7M 1.21% +25,000 Timeline INCY INCYTE CORP More: the full row for INCYTE CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 160,000 shares 160,000 $19.4M 1.19% new Timeline DFTX DEFINIUM THERAPEUTICS INC More: the full row for DEFINIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 400,000 shares; 2026Q2: 550,000 shares; 2026Q3: 500,000 shares 500,000 $19M 1.16% -50,000 Timeline BTSG BRIGHTSPRING HEALTH SVCS INC More: the full row for BRIGHTSPRING HEALTH SVCS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 950,000 shares; 2025Q1: 775,000 shares; 2025Q2: 1,250,000 shares; 2025Q3: 1,150,000 shares; 2025Q4: 750,000 shares; 2026Q1: 1,250,000 shares; 2026Q2: 550,000 shares; 2026Q3: 325,000 shares 325,000 $18.4M 1.13% -225,000 Timeline ONC BEONE MEDICINES LTD More: the full row for BEONE MEDICINES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000 $18.3M 1.12% new Timeline ROIV ROIVANT SCIENCES LTD More: the full row for ROIVANT SCIENCES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 600,000 shares; 2025Q2: 600,000 shares; 2025Q3: 750,000 shares; 2025Q4: 850,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 2,000,000 shares; 2026Q3: 2,000,000 shares 2,000,000 $18.3M 1.12% 0 Timeline LBRX LB PHARMACEUTICALS INC More: the full row for LB PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 150,000 shares; 2026Q2: 150,000 shares; 2026Q3: 470,000 shares 470,000 $18M 1.1% +320,000 Timeline BDX BECTON DICKINSON & CO More: the full row for BECTON DICKINSON & CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 20,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000 $17.9M 1.09% new Timeline BSX BOSTON SCIENTIFIC CORP More: the full row for BOSTON SCIENTIFIC CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 550,000 shares; 2025Q1: 650,000 shares; 2025Q2: 550,000 shares; 2025Q3: 300,000 shares; 2025Q4: 225,000 shares; 2026Q1: 550,000 shares; 2026Q2: 900,000 shares; 2026Q3: 400,000 shares 400,000 $17.5M 1.07% -500,000 Timeline EW EDWARDS LIFESCIENCES CORP More: the full row for EDWARDS LIFESCIENCES CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 125,000 shares; 2025Q2: 200,000 shares; 2025Q3: 200,000 shares; 2025Q4: 325,000 shares; 2026Q1: 170,000 shares; 2026Q2: 625,000 shares; 2026Q3: 200,000 shares 200,000 $17.3M 1.06% -425,000 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 700,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,130,000 shares 1,130,000 $16.6M 1.01% +130,000 Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 150,000 shares; 2025Q2: 100,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,000 shares; 2026Q3: 375,000 shares 375,000 $15.2M 0.93% +275,000 Timeline MDT MEDTRONIC PLC More: the full row for MEDTRONIC PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 150,000 shares; 2025Q1: 300,000 shares; 2025Q2: 200,000 shares; 2025Q3: 150,000 shares; 2025Q4: 675,000 shares; 2026Q1: not reported; 2026Q2: 200,000 shares; 2026Q3: 175,000 shares 175,000 $15.1M 0.92% -25,000 Timeline GKOS GLAUKOS CORP More: the full row for GLAUKOS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,000 shares; 2025Q3: 100,000 shares; 2025Q4: 325,000 shares; 2026Q1: 175,000 shares; 2026Q2: 150,000 shares; 2026Q3: 90,000 shares 90,000 $14.8M 0.9% -60,000 Timeline EHC ENCOMPASS HEALTH CORP More: the full row for ENCOMPASS HEALTH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 300,000 shares; 2025Q1: 270,000 shares; 2025Q2: 320,000 shares; 2025Q3: 200,000 shares; 2025Q4: 100,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 120,000 shares 120,000 $14.6M 0.89% new Timeline NVS NOVARTIS AG More: the full row for NOVARTIS AG Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 250,000 shares; 2025Q2: 200,000 shares; 2025Q3: 200,000 shares; 2025Q4: 250,000 shares; 2026Q1: 250,000 shares; 2026Q2: 200,000 shares; 2026Q3: 100,000 shares 100,000 $14.3M 0.87% -100,000 Timeline ABSI ABSCI CORPORATION More: the full row for ABSCI CORPORATION Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 800,000 shares; 2026Q3: 1,300,000 shares 1,300,000 $14M 0.86% +500,000 Timeline DGX QUEST DIAGNOSTICS INC More: the full row for QUEST DIAGNOSTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 130,000 shares; 2025Q1: not reported; 2025Q2: 150,000 shares; 2025Q3: 85,000 shares; 2025Q4: 75,000 shares; 2026Q1: 60,000 shares; 2026Q2: 200,000 shares; 2026Q3: 55,000 shares 55,000 $12.8M 0.78% -145,000 Timeline ANRO ALTO NEUROSCIENCE INC More: the full row for ALTO NEUROSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 300,000 shares; 2025Q1: 400,000 shares; 2025Q2: 400,000 shares; 2025Q3: 400,000 shares; 2025Q4: 375,000 shares; 2026Q1: 500,000 shares; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000 $12.8M 0.78% 0 Timeline MDGL MADRIGAL PHARMACEUTICALS INC More: the full row for MADRIGAL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 25,000 shares; 2026Q2: 25,000 shares; 2026Q3: 25,000 shares 25,000 $12.6M 0.77% 0 Timeline BMY BRISTOL-MYERS SQUIBB CO More: the full row for BRISTOL-MYERS SQUIBB CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 350,000 shares; 2025Q1: 100,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000 $12.5M 0.76% new Timeline QURE UNIQURE NV More: the full row for UNIQURE NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,100,000 shares; 2025Q1: 1,250,000 shares; 2025Q2: 1,350,000 shares; 2025Q3: 600,000 shares; 2025Q4: 900,000 shares; 2026Q1: 900,000 shares; 2026Q2: 900,000 shares; 2026Q3: 500,000 shares 500,000 $12.1M 0.74% -400,000 Timeline RYTM RHYTHM PHARMACEUTICALS INC More: the full row for RHYTHM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 150,000 shares; 2025Q1: not reported; 2025Q2: 120,000 shares; 2025Q3: 220,000 shares; 2025Q4: 475,000 shares; 2026Q1: 600,000 shares; 2026Q2: 550,000 shares; 2026Q3: 250,000 shares 250,000 $11.9M 0.73% -300,000 Timeline TEVA TEVA PHARMACEUTICAL INDS LTD More: the full row for TEVA PHARMACEUTICAL INDS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000 $11.9M 0.73% new Timeline TVTX TRAVERE THERAPEUTICS INC More: the full row for TRAVERE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 100,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 375,000 shares; 2026Q3: 200,000 shares 200,000 $11.8M 0.72% -175,000 Timeline PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 40,000 shares; 2026Q1: 40,000 shares; 2026Q2: 40,000 shares; 2026Q3: 40,000 shares 40,000 $11.6M 0.71% 0 Timeline LIVANOVA PLC LIVANOVA PLC More: the full row for LIVANOVA PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 150,000 shares 150,000 $11.5M 0.7% new WAT WATERS CORP More: the full row for WATERS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 30,000 shares; 2025Q1: 20,000 shares; 2025Q2: 15,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 40,000 shares; 2026Q3: 25,000 shares 25,000 $11M 0.67% -15,000 Timeline SRZN SURROZEN INC More: the full row for SURROZEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 325,000 shares 325,000 $10.5M 0.64% new Timeline INSP INSPIRE MED SYS INC More: the full row for INSPIRE MED SYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 100,000 shares; 2025Q1: 65,000 shares; 2025Q2: 70,000 shares; 2025Q3: 120,000 shares; 2025Q4: 75,000 shares; 2026Q1: not reported; 2026Q2: 100,000 shares; 2026Q3: 150,000 shares 150,000 $10.4M 0.64% +50,000 Timeline MLYS MINERALYS THERAPEUTICS INC More: the full row for MINERALYS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 875,000 shares; 2025Q1: 2,300,000 shares; 2025Q2: 2,700,000 shares; 2025Q3: 1,500,000 shares; 2025Q4: 750,000 shares; 2026Q1: 750,000 shares; 2026Q2: 450,000 shares; 2026Q3: 400,000 shares 400,000 $10.1M 0.61% -50,000 Timeline TYRA TYRA BIOSCIENCES INC More: the full row for TYRA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 455,000 shares 455,000 $9.95M 0.61% new Timeline TMO THERMO FISHER SCIENTIFIC INC More: the full row for THERMO FISHER SCIENTIFIC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,000 shares; 2026Q2: not reported; 2026Q3: 14,000 shares 14,000 $9.45M 0.58% new Timeline RGNX REGENXBIO INC More: the full row for REGENXBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 900,000 shares; 2025Q1: 925,000 shares; 2025Q2: 700,000 shares; 2025Q3: 1,100,000 shares; 2025Q4: 1,200,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 800,000 shares; 2026Q3: 1,200,000 shares 1,200,000 $9.04M 0.55% +400,000 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 325,000 shares; 2026Q3: 325,000 shares 325,000 $8.9M 0.54% 0 Timeline OVID OVID THERAPEUTICS INC More: the full row for OVID THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,500,000 shares 3,500,000 $8.71M 0.53% new Timeline COO COOPER COS INC More: the full row for COOPER COS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 100,000 shares; 2025Q1: not reported; 2025Q2: 70,000 shares; 2025Q3: 95,000 shares; 2025Q4: 325,000 shares; 2026Q1: 150,000 shares; 2026Q2: not reported; 2026Q3: 150,000 shares 150,000 $8.48M 0.52% new Timeline CLYM CLIMB BIO INC More: the full row for CLIMB BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 700,000 shares 700,000 $8.03M 0.49% new Timeline ATTO ATTOVIA THERAPEUTICS INC More: the full row for ATTOVIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000 $7.71M 0.47% new Timeline ALNY ALNYLAM PHARMACEUTICALS INC More: the full row for ALNYLAM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 45,000 shares; 2025Q1: 50,000 shares; 2025Q2: 55,000 shares; 2025Q3: 60,000 shares; 2025Q4: 60,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 30,000 shares 30,000 $7.4M 0.45% new Timeline FTH FAETH THERAPEUTICS INC More: the full row for FAETH THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 240,000 shares 240,000 $7.14M 0.44% new Timeline GH GUARDANT HEALTH INC More: the full row for GUARDANT HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 40,000 shares 40,000 $7.13M 0.44% new Timeline TGTX TG THERAPEUTICS INC More: the full row for TG THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 150,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 125,000 shares 125,000 $6.97M 0.43% new Timeline IONS IONIS PHARMACEUTICALS INC More: the full row for IONIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 125,000 shares; 2026Q2: not reported; 2026Q3: 150,000 shares 150,000 $6.7M 0.41% new Timeline VOR VOR BIOPHARMA INC More: the full row for VOR BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 350,000 shares 350,000 $6.68M 0.41% new Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 350,000 shares; 2026Q2: 200,000 shares; 2026Q3: 200,000 shares 200,000 $6.4M 0.39% 0 Timeline TXG 10X GENOMICS INC More: the full row for 10X GENOMICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 70,000 shares 70,000 $6.33M 0.39% new Timeline HELP CYBIN INC More: the full row for CYBIN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000 $6.14M 0.38% new Timeline IMTX IMMATICS N.V More: the full row for IMMATICS N.V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 690,000 shares 690,000 $6.06M 0.37% new Timeline SANA SANA BIOTECHNOLOGY INC More: the full row for SANA BIOTECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,000,000 shares; 2025Q1: 2,000,000 shares; 2025Q2: 1,500,000 shares; 2025Q3: 2,000,000 shares; 2025Q4: 3,000,000 shares; 2026Q1: 3,200,000 shares; 2026Q2: 2,000,000 shares; 2026Q3: 2,000,000 shares 2,000,000 $5.83M 0.36% 0 Timeline CMPS COMPASS PATHWAYS PLC More: the full row for COMPASS PATHWAYS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 200,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 460,000 shares 460,000 $5.72M 0.35% new Timeline NGNE NEUROGENE INC More: the full row for NEUROGENE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000 $5.56M 0.34% new Timeline ALMS ALUMIS INC More: the full row for ALUMIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 800,000 shares; 2026Q2: 700,000 shares; 2026Q3: 700,000 shares 700,000 $5.17M 0.32% 0 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000 $4.95M 0.3% new Timeline APMD APNIMED INC More: the full row for APNIMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 225,000 shares 225,000 $4.93M 0.3% new Timeline BEAM BEAM THERAPEUTICS INC More: the full row for BEAM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 500,000 shares; 2025Q3: 400,000 shares; 2025Q4: 550,000 shares; 2026Q1: 300,000 shares; 2026Q2: 300,000 shares; 2026Q3: 200,000 shares 200,000 $4.89M 0.3% -100,000 Timeline IVA INVENTIVA SA More: the full row for INVENTIVA SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 400,000 shares; 2026Q2: 1,520,000 shares; 2026Q3: 1,300,000 shares 1,300,000 $4.8M 0.29% -220,000 Timeline CTNM CONTINEUM THERAPEUTICS INC More: the full row for CONTINEUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 345,000 shares 345,000 $4.63M 0.28% new Timeline ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 150,000 shares; 2026Q3: 100,000 shares 100,000 $4.58M 0.28% -50,000 Timeline BHVN BIOHAVEN LTD More: the full row for BIOHAVEN LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 175,000 shares; 2025Q2: 300,000 shares; 2025Q3: 650,000 shares; 2025Q4: 1,500,000 shares; 2026Q1: 1,000,000 shares; 2026Q2: 700,000 shares; 2026Q3: 300,000 shares 300,000 $4M 0.24% -400,000 Timeline IDYA IDEAYA BIOSCIENCES INC More: the full row for IDEAYA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000 $3.84M 0.23% 0 Timeline TARA PROTARA THERAPEUTICS INC More: the full row for PROTARA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,400,000 shares; 2025Q1: 1,400,000 shares; 2025Q2: 1,400,000 shares; 2025Q3: 1,400,000 shares; 2025Q4: 2,250,000 shares; 2026Q1: 1,750,000 shares; 2026Q2: 1,500,000 shares; 2026Q3: 1,250,000 shares 1,250,000 $3.81M 0.23% -250,000 Timeline NRIX NURIX THERAPEUTICS INC More: the full row for NURIX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 250,000 shares; 2025Q1: 275,000 shares; 2025Q2: 310,000 shares; 2025Q3: 350,000 shares; 2025Q4: 300,000 shares; 2026Q1: 700,000 shares; 2026Q2: not reported; 2026Q3: 160,000 shares 160,000 $3.79M 0.23% new Timeline GLUE MONTE ROSA THERAPEUTICS INC More: the full row for MONTE ROSA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000 $3.58M 0.22% new Timeline KARD KARDIGAN INC More: the full row for KARDIGAN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares; 2026Q3: 225,000 shares 225,000 $3.32M 0.2% +25,000 Timeline SVRA SAVARA INC More: the full row for SAVARA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 600,000 shares; 2026Q2: 600,000 shares; 2026Q3: 600,000 shares 600,000 $3.1M 0.19% 0 Timeline CAI CARIS LIFE SCIENCES INC More: the full row for CARIS LIFE SCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000 $3.06M 0.19% new Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares; 2026Q3: 200,000 shares 200,000 $2.86M 0.18% 0 Timeline IKT INHIBIKASE THERAPEUTICS INC More: the full row for INHIBIKASE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,750,000 shares; 2026Q1: 1,350,000 shares; 2026Q2: 1,350,000 shares; 2026Q3: 1,350,000 shares 1,350,000 $2.77M 0.17% 0 Timeline MAZE MAZE THERAPEUTICS INC More: the full row for MAZE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000 $2.72M 0.17% new Timeline AGMB AGOMAB THERAPEUTICS NV More: the full row for AGOMAB THERAPEUTICS NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 235,000 shares 235,000 $2.61M 0.16% new Timeline ETRA ELECTRA THERAPEUTICS INC More: the full row for ELECTRA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000 $2.25M 0.14% new Timeline BRVE BRAVEHEART BIO INC More: the full row for BRAVEHEART BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000 $2.02M 0.12% new Timeline CAMP CAMP4 THERAPEUTICS CORP More: the full row for CAMP4 THERAPEUTICS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 495,000 shares 495,000 $2M 0.12% new Timeline ACRS ACLARIS THERAPEUTICS INC More: the full row for ACLARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000 $1.05M 0.06% new Timeline XFOR X4 PHARMACEUTICALS INC More: the full row for X4 PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000 $725K 0.04% new Timeline